AKT1 and cancer: Although TFAP4 has been reported in cancer cells to mediate cell fate decisions by diverse mechanisms including the PI3K/Akt pathway (Huang et al, 2019; Wong et al, 2021), to our knowledge, TFAP4 has not previously been studied in muscle progenitor cells.